
Congress trades
Novartis AG (NVS)
NYSE · Healthcare · 65 congress trades · last filed 2 months ago
About Novartis AG
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Vasant Narasimhan
- Employees
- 75,267
- Listed since
- Nov 7, 1996
- Market value
- $261.3B
- Price to earnings
- 21.0
- Earnings per share
- $6.64
- Dividend yield
- 3.29%
Earnings
6 reported quarters · next on Oct 27, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 21, 2026 | $2.41 | $2.17 | $14.4B | $14.1B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 28, 2026 | $1.99 | $2.11 | $13.1B | $13.4B | EPS missRevenue miss |
| Q4 FY2025reported Feb 4, 2026 | $2.03 | $1.99 | $13.3B | $13.7B | EPS beatRevenue miss |
| Q3 FY2025reported Oct 28, 2025 | $2.25 | $2.26 | $14.4B | $13.6B | EPS in lineRevenue beat |
| Q2 FY2025reported Jul 17, 2025 | $2.42 | $2.38 | $14.3B | $13.9B | EPS beatRevenue beat |
| Apr 29, 2025 | $2.28 | $2.12 | $13.6B | $13.9B | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Fisher Asset Management, LLC | $2.4B | 15,523,378 | +11.8% | 0.81% |
| Morgan Stanley | $1.4B | 8,726,827 | +2.3% | 0.46% |
| Dimensional Fund Advisors LP | $1.3B | 8,117,586 | +0.1% | 0.43% |
| Primecap Management Co | $1.0B | 6,592,124 | -12.9% | 0.35% |
| Loomis Sayles & Co L P | $821.1M | 5,239,309 | -3.4% | 0.28% |
| Bank Of America Corp | $769.5M | 4,909,938 | -1.1% | 0.26% |
| Franklin Resources Inc | $509.5M | 3,251,281 | -4.7% | 0.17% |
| Blackrock, Inc. | $477.7M | 3,047,988 | +3.3% | 0.16% |
| Goldman Sachs Group Inc | $467.1M | 2,980,168 | -54.3% | 0.16% |
| Northern Trust Corp | $437.7M | 2,792,745 | +0.2% | 0.15% |
| Natixis Advisors, L.P. | $374.0M | 2,386,527 | +6.7% | 0.13% |
| Envestnet Asset Management Inc | $365.3M | 2,330,979 | +0.8% | 0.12% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in NVS
20 disclosures of 65 on record · median 30d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $15,001 - $50,000 | -8.6%S&P +20.7% · vs S&P 500 -29.2% | Mar 30, 2026 | Jul 21, 2026 | 113d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | -10.0%S&P +17.3% · vs S&P 500 -27.3% | Mar 31, 2026 | Jul 21, 2026 | 112d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -10.4%S&P +15.1% · vs S&P 500 -25.5% | Mar 13, 2026 | Apr 7, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -15.7%S&P +11.8% · vs S&P 500 -27.5% | Feb 13, 2026 | Mar 9, 2026 | 24d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +11.1%S&P +11.8% · vs S&P 500 -0.7% | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +12.8%S&P +12.3% · vs S&P 500 +0.5% | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClain | Stock | Sale | $1,001 - $15,000 | n/a | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +13.1%S&P +15.7% · vs S&P 500 -2.6% | Sep 25, 2025 | Oct 22, 2025 | 27d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +8.3%S&P +16.1% · vs S&P 500 -7.8% | Sep 11, 2025 | Oct 22, 2025 | 41d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +17.2%S&P +27.3% · vs S&P 500 -10.2% | Jun 9, 2025 | Aug 13, 2025 | 65d |
| Lisa C. McClainSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +16.6%S&P +26.6% · vs S&P 500 -10.0% | Jun 10, 2025 | Aug 13, 2025 | 64d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +17.1%S&P +27.0% · vs S&P 500 -9.9% | Jun 11, 2025 | Aug 13, 2025 | 63d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +18.8%S&P +27.8% · vs S&P 500 -9.0% | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +18.4%S&P +21.5% · vs S&P 500 -3.1% | Jul 22, 2025 | Aug 13, 2025 | 22d |
| George Whitesides | Stock | Sale | $100,001 - $250,000 | +23.8%S&P +32.4% · vs S&P 500 -8.6% | Mar 24, 2025 | Apr 23, 2025 | 30d |
| Sheldon WhitehouseSelf | Stock | Sale (Partial) | $1,001 - $15,000 | +43.5%S&P +46.9% · vs S&P 500 -3.4% | Apr 9, 2024 | May 20, 2024 | 41d |
| Ro Khanna | Stock | Exchange | n/a | n/a | Mar 5, 2024 | Mar 6, 2024 | 1d |
| Sheldon WhitehouseSelf | Stock | Purchase | $15,001 - $50,000 | +32.7%S&P +73.3% · vs S&P 500 -40.5% | Sep 20, 2023 | Oct 17, 2023 | 27d |
| Daniel S. Goldman | Stock | Sale | $50,001 - $100,000 | n/a | Jul 10, 2023 | Aug 13, 2023 | 34d |
| Daniel S. Goldman | Stock | Purchase | $50,001 - $100,000 | +49.4%S&P +86.4% · vs S&P 500 -36.9% | Mar 31, 2023 | Apr 17, 2023 | 17d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
8 members · estimate, as of Sep 10, 20268 members report a position (estimated). The largest estimated position is in the $100,001 - $250,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| John W. Hickenlooper | Democrat · Senate | $100,001 - $250,000 | 1.0% |
| Debbie Dingell | Democrat · House | $50,001 - $100,000 | 1.0% |
| Jacky Rosen | Democrat · Senate | $15,001 - $50,000 | 0.8% |
| Kevin Hern | Republican · House | $15,001 - $50,000 | 0.1% |
| Mark Harris | Republican · House | $15,001 - $50,000 | 1.2% |
| Randy Fine | Republican · House | $15,001 - $50,000 | 0.9% |
| Sheldon Whitehouse | Democrat · Senate | $1,001 - $15,000 | 0.1% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.5% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded NVS?
Alan Armstrong, Ro Khanna, Lisa C. McClain, George Whitesides, Sheldon Whitehouse, Daniel S. Goldman disclosed NVS transactions in the filings shown here.
Which members of Congress hold NVS?
8 members of Congress report a position in NVS in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to John W. Hickenlooper, Debbie Dingell and Jacky Rosen. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are NVS trades disclosed?
Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
